Synthetic Biology and AI DOI

Archana Lakshmaiah,

Chandana Korrapati,

Suresh Challa

и другие.

Advances in medical diagnosis, treatment, and care (AMDTC) book series, Год журнала: 2024, Номер unknown, С. 265 - 290

Опубликована: Дек. 17, 2024

Synthetic biology and artificial intelligence are ushering in a new era of healthcare. In the specific context bioengineering, organoids, brain-computer interfaces, ethical considerations particularly salient. Challenges such as data inadequacy, unintended bias can undermine reliability fairness decision making. Additionally, cultural barriers concerns related to nonmaleficence, autonomy, justice must be carefully considered. To fully realize benefits this technological synergy, multidisciplinary approach is necessary, involving scientists, engineers, ethicists, policymakers. Transparent accountable AI systems essential mitigate biases, protect privacy, avoid consequences. By proactively addressing developing robust regulatory frameworks, we harness power these technologies for betterment humanity.

Язык: Английский

Human kidney organoids for modeling the development of different diseases DOI
Elena Ceccotti,

Armina Semnani,

Benedetta Bussolati

и другие.

Current topics in developmental biology/Current Topics in Developmental Biology, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Язык: Английский

Процитировано

1

Advances in cardiac organoid research: implications for cardiovascular disease treatment DOI Creative Commons

Ziteng Huang,

Keran Jia,

Yadan Tan

и другие.

Cardiovascular Diabetology, Год журнала: 2025, Номер 24(1)

Опубликована: Янв. 18, 2025

Globally, cardiovascular diseases remain among the leading causes of mortality, highlighting urgent need for innovative research models. Consequently, development accurate models that simulate cardiac function holds significant scientific and clinical value both disease therapeutic interventions. Cardiac organoids, which are three-dimensional structures derived from induced differentiation stem cells, particularly promising. These organoids not only replicate autonomous beating essential electrophysiological properties heart but also widely employed in studies related to diseases, drug efficacy testing, regenerative medicine. This review comprehensively surveys various fabrication techniques used create their diverse applications modeling a range diseases. We emphasize role advanced technologies enhancing maturation functionality ensuring these closely resemble native tissue. Furthermore, we discuss monitoring evaluation parameters critical assessing performance considering complex interactions within multi-organ systems. approach is vital precision efficiency development, allowing more effective strategies. Ultimately, this aims provide thorough perspective on fundamental treatment offering insights could pave way future advancements understanding addressing prevalent health challenges.

Язык: Английский

Процитировано

0

Advances in humanoid organoid-based research on inter-organ communications during cardiac organogenesis and cardiovascular diseases DOI Creative Commons

Baoqiang Ni,

Lingqun Ye, Yan Zhang

и другие.

Journal of Translational Medicine, Год журнала: 2025, Номер 23(1)

Опубликована: Март 28, 2025

The intimate correlation between cardiovascular diseases and other organ pathologies, such as metabolic kidney diseases, underscores the intricate interactions among these organs. Understanding inter-organ communications is crucial for developing more precise drugs effective treatments systemic diseases. While animal models have traditionally been pivotal in studying interactions, human-induced pluripotent stem cells (hiPSCs) offer distinct advantages when constructing vitro models. Beyond conventional two-dimensional co-culture model, hiPSC-derived humanoid organoids emerged a substantial advancement, capable of replicating essential structural functional attributes internal organs vitro. This breakthrough has spurred development multilineage organoids, assembloids, organoids-on-a-chip technologies, which allow enhanced physiological relevance. These technologies shown great potential mimicking coordinated organogenesis, exploring disease pathogenesis, facilitating drug discovery. As central system, heart serves focal point an extensively studied network interactions. review focuses on advancements challenges organs, presenting comprehensive exploration this cutting-edge approach research.

Язык: Английский

Процитировано

0

Advancements in Research on Genetic Kidney Diseases Using Human-Induced Pluripotent Stem Cell-Derived Kidney Organoids DOI Creative Commons
Do-hyun Na, Sheng Cui, Xianying Fang

и другие.

Cells, Год журнала: 2024, Номер 13(14), С. 1190 - 1190

Опубликована: Июль 13, 2024

Genetic or hereditary kidney disease stands as a pivotal cause of chronic (CKD). The proliferation and widespread utilization DNA testing in clinical settings have notably eased the diagnosis genetic diseases, which were once elusive but are now increasingly identified cases previously deemed CKD unknown etiology. However, despite these diagnostic strides, research into pathogenesis novel drug development faces significant hurdles, chiefly due to dearth appropriate animal models challenges posed by limited patient cohorts studies. Conversely, advent human-induced pluripotent stem cells (hiPSCs) offer promising avenue for research. Particularly, hiPSC-derived organoid systems presents platform investigating various forms diseases. Moreover, integration CRISPR/Cas9 technique this system holds immense potential efficient on This review aims explore applications vitro organoids generated from hiPSCs study diverse Additionally, it will delve limitations outline future perspectives advancing crucial area.

Язык: Английский

Процитировано

3

hPSCs-derived brain organoids for disease modeling, toxicity testing and drug evaluation DOI
Na Xie, Jinrong Bai,

Ya Hou

и другие.

Experimental Neurology, Год журнала: 2024, Номер 385, С. 115110 - 115110

Опубликована: Дек. 10, 2024

Язык: Английский

Процитировано

1

人源类器官表型组学的研究进展及展望 DOI
Wendiao Zhang,

XingYu YIN,

Hongwei Gu

и другие.

Scientia Sinica Vitae, Год журнала: 2024, Номер 54(11), С. 2125 - 2142

Опубликована: Июль 24, 2024

Процитировано

0

Synthetic Biology and AI DOI

Archana Lakshmaiah,

Chandana Korrapati,

Suresh Challa

и другие.

Advances in medical diagnosis, treatment, and care (AMDTC) book series, Год журнала: 2024, Номер unknown, С. 265 - 290

Опубликована: Дек. 17, 2024

Synthetic biology and artificial intelligence are ushering in a new era of healthcare. In the specific context bioengineering, organoids, brain-computer interfaces, ethical considerations particularly salient. Challenges such as data inadequacy, unintended bias can undermine reliability fairness decision making. Additionally, cultural barriers concerns related to nonmaleficence, autonomy, justice must be carefully considered. To fully realize benefits this technological synergy, multidisciplinary approach is necessary, involving scientists, engineers, ethicists, policymakers. Transparent accountable AI systems essential mitigate biases, protect privacy, avoid consequences. By proactively addressing developing robust regulatory frameworks, we harness power these technologies for betterment humanity.

Язык: Английский

Процитировано

0